BACKGROUND/ OBJECTIVES: Brief cognitive screens lack the sensitivity to detect mild cognitive impairment (MCI) or support differential diagnoses. The objective of this study was to validate the 10-minute, tablet-based University of California, San Francisco (UCSF) Brain Health Assessment (BHA) to overcome these limitations. DESIGN: Cross-sectional. SETTING: UCSF Memory and Aging Center. PARTICIPANTS: Older adults (N = 347) (neurologically healthy controls (n = 185), and individuals diagnosed with MCI (n = 99), dementia (n = 42), and as normal with concerns (n = 21)). MEASUREMENTS: The BHA includes subtests of memory, executive function and speed, visuospatial skills, and language and an optional informant survey. Participants completed the Montreal Cognitive Assessment (MoCA) and criterion-standard neuropsychological tests. Standardized structural 3T brain magnetic resonance imaging was performed in 145 participants. RESULTS: At a fixed 85% specificity rate, the BHA had 100% sensitivity to dementia and 84% to MCI; the MoCA had 75% sensitivity to dementia and 25% to MCI. The BHA had 83% sensitivity to MCI likely due to AD and 88% to MCI unlikely due to AD, and the MoCA had 58% sensitivity to MCI likely AD and 24% to MCI unlikely AD. The BHA subtests demonstrated moderate to high correlations with the criterion-standard tests from their respective cognitive domains. Memory test performance correlated with medial temporal lobe volumes; executive and speed with frontal, parietal, and basal ganglia volumes; and visuospatial with right parietal volumes. CONCLUSION: The BHA had excellent combined sensitivity and specificity to detect dementia and MCI, including MCI due to diverse etiologies. The subtests provide efficient, valid measures of neurocognition that are critical in making a differential diagnosis.
BACKGROUND/ OBJECTIVES: Brief cognitive screens lack the sensitivity to detect mild cognitive impairment (MCI) or support differential diagnoses. The objective of this study was to validate the 10-minute, tablet-based University of California, San Francisco (UCSF) Brain Health Assessment (BHA) to overcome these limitations. DESIGN: Cross-sectional. SETTING: UCSF Memory and Aging Center. PARTICIPANTS: Older adults (N = 347) (neurologically healthy controls (n = 185), and individuals diagnosed with MCI (n = 99), dementia (n = 42), and as normal with concerns (n = 21)). MEASUREMENTS: The BHA includes subtests of memory, executive function and speed, visuospatial skills, and language and an optional informant survey. Participants completed the Montreal Cognitive Assessment (MoCA) and criterion-standard neuropsychological tests. Standardized structural 3T brain magnetic resonance imaging was performed in 145 participants. RESULTS: At a fixed 85% specificity rate, the BHA had 100% sensitivity to dementia and 84% to MCI; the MoCA had 75% sensitivity to dementia and 25% to MCI. The BHA had 83% sensitivity to MCI likely due to AD and 88% to MCI unlikely due to AD, and the MoCA had 58% sensitivity to MCI likely AD and 24% to MCI unlikely AD. The BHA subtests demonstrated moderate to high correlations with the criterion-standard tests from their respective cognitive domains. Memory test performance correlated with medial temporal lobe volumes; executive and speed with frontal, parietal, and basal ganglia volumes; and visuospatial with right parietal volumes. CONCLUSION: The BHA had excellent combined sensitivity and specificity to detect dementia and MCI, including MCI due to diverse etiologies. The subtests provide efficient, valid measures of neurocognition that are critical in making a differential diagnosis.
Authors: Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps Journal: Alzheimers Dement Date: 2011-04-21 Impact factor: 21.566
Authors: Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman Journal: Neurology Date: 2011-02-16 Impact factor: 9.910
Authors: Sarah Tomaszewski Farias; Dan Mungas; Danielle J Harvey; Amanda Simmons; Bruce R Reed; Charles Decarli Journal: Alzheimers Dement Date: 2011-11 Impact factor: 21.566
Authors: Soo Borson; Lori Frank; Peter J Bayley; Malaz Boustani; Marge Dean; Pei-Jung Lin; J Riley McCarten; John C Morris; David P Salmon; Frederick A Schmitt; Richard G Stefanacci; Marta S Mendiondo; Susan Peschin; Eric J Hall; Howard Fillit; J Wesson Ashford Journal: Alzheimers Dement Date: 2013-01-30 Impact factor: 21.566
Authors: Katherine L Possin; Victor R Laluz; Oscar Z Alcantar; Bruce L Miller; Joel H Kramer Journal: Neuropsychologia Date: 2010-10-26 Impact factor: 3.139
Authors: Jennifer S Lin; Elizabeth O'Connor; Rebecca C Rossom; Leslie A Perdue; Elizabeth Eckstrom Journal: Ann Intern Med Date: 2013-11-05 Impact factor: 25.391
Authors: Andrea G Alioto; Paige Mumford; Amy Wolf; Kaitlin B Casaletto; Sabrina Erlhoff; Tacie Moskowitz; Joel H Kramer; Katherine P Rankin; Katherine L Possin Journal: J Int Neuropsychol Soc Date: 2019-04-26 Impact factor: 2.892
Authors: Alexander J Ehrenberg; Ayesha Khatun; Emma Coomans; Matthew J Betts; Federica Capraro; Elisabeth H Thijssen; Konstantin Senkevich; Tehmina Bharucha; Mehrsa Jafarpour; Peter N E Young; William Jagust; Stephen F Carter; Tammaryn Lashley; Lea T Grinberg; Joana B Pereira; Niklas Mattsson-Carlgren; Nicholas J Ashton; Jörg Hanrieder; Henrik Zetterberg; Michael Schöll; Ross W Paterson Journal: Alzheimers Res Ther Date: 2020-05-13 Impact factor: 6.982
Authors: Riley M Bove; Gillian Rush; Chao Zhao; William Rowles; Priya Garcha; John Morrissey; Adrian Schembri; Titi Alailima; Dawn Langdon; Katherine Possin; Adam Gazzaley; Anthony Feinstein; Joaquin Anguera Journal: Neurol Ther Date: 2018-11-30
Authors: Ana M Rodríguez-Salgado; Jorge J Llibre-Guerra; Elena Tsoy; Ana Ibis Peñalver-Guia; Giosmany Bringas; Sabrina J Erlhoff; Joel H Kramer; Isabel Elaine Allen; Victor Valcour; Bruce L Miller; Juan J Llibre-Rodríguez; Katherine L Possin Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Stefan Junge; Paul Gellert; Julie Lorraine O'Sullivan; Sebastian Möller; Jan-Niklas Voigt-Antons; Adelheid Kuhlmey; Johanna Nordheim Journal: Qual Life Res Date: 2020-01-18 Impact factor: 4.147